Problem: Misinformation and stigma prevent uptake of HPV vaccines and screening. Solution: A comic book

No need for a speculum? A new era of HPV screening

FDA has cleared the first at-home self-collection kit for HPV screening, removing significant obstacles to cervical cancer detection.

April 22, 2026

Clinical Roundup

Merck to present long-term data of Gardasil 9 and Gardasil at the EUROGIN international multidisciplinary HPV Congress

Clinical, real-world data reaffirming the long-term effectiveness of Gardasil 9 (Human Papillomavirus 9-valent Vaccine, Recombinant) and Gardasil (Human Papillomavirus 4-valent Vaccine, Recombinant) against certain HPV-related cancers and diseases will be presented at the EUROGIN International Multidisciplinary HPV Congress 2026 in Vienna, Austria, March 18-21.

March 20, 2026

Vol.52 No.11

Clinical Roundup

HPV cancer vaccine slows tumor growth, extends survival in animal models

Throughout the past decade, Northwestern University scientists have uncovered a striking principle of vaccine design: Performance depends not only on vaccine components but also on vaccine structure.

February 13, 2026

Vol.52 No.06

Clinical Roundup

Preclinical study reveals how HPV reprograms immune cells to help cancer grow

The most common cancer-causing strain of human papillomavirus, HPV16, undermines the body’s defenses by reprogramming immune cells surrounding the tumor, according to a preclinical study from researchers at the Keck School of Medicine of USC. In mice, blocking this process boosted the ability of experimental treatments for HPV to eliminate cancer cells.

September 12, 2025

Vol.51 No.33

In Brief

Henry Ford + MSU researchers granted $3M from NIH to study HPV-positive head-and-neck cancers

The National Institute of Dental and Craniofacial Research awarded a $3 million grant to researchers from Henry Ford Health + Michigan State University Health Sciences to study new treatments for patients who have head-and-neck cancer caused by HPV.

July 25, 2025

Vol.51 No.29

Clinical

Survey reveals most Americans are uninformed about HPV
A vaccine can prevent cancer—most people don’t take it

Each year, nearly 14 million people in the U.S. contract human papillomavirus, a common, sexually-transmitted virus that can cause several cancers.

March 07, 2025

Vol.51 No.09

By Claire Marie Porter

Problem: Misinformation and stigma prevent uptake of HPV vaccines and screening. Solution: A comic book

YOU MAY BE INTERESTED IN

No need for a speculum? A new era of HPV screening

Merck to present long-term data of Gardasil 9 and Gardasil at the EUROGIN international multidisciplinary HPV Congress

HPV cancer vaccine slows tumor growth, extends survival in animal models

Preclinical study reveals how HPV reprograms immune cells to help cancer grow

Henry Ford + MSU researchers granted $3M from NIH to study HPV-positive head-and-neck cancers

Survey reveals most Americans are uninformed about HPV
A vaccine can prevent cancer—most people don’t take it

Renew today!

Subscriber content

Never miss an issue!

Login

Problem: Misinformation and stigma prevent uptake of HPV vaccines and screening. Solution: A comic book

YOU MAY BE INTERESTED IN

No need for a speculum? A new era of HPV screening

Merck to present long-term data of Gardasil 9 and Gardasil at the EUROGIN international multidisciplinary HPV Congress

HPV cancer vaccine slows tumor growth, extends survival in animal models

Preclinical study reveals how HPV reprograms immune cells to help cancer grow

Henry Ford + MSU researchers granted $3M from NIH to study HPV-positive head-and-neck cancers

Survey reveals most Americans are uninformed about HPVA vaccine can prevent cancer—most people don’t take it

Never miss an issue!

Login

Survey reveals most Americans are uninformed about HPV
A vaccine can prevent cancer—most people don’t take it